ArticleMicrobial cell factories2026
Fungal-fungal interaction between Sanghuangporus vaninii and its endophytic Fusarium solani rewires host secondary metabolism to boost bioactive metabolite production.
Article in Microbial cell factories, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundThe medicinal mushroom Sanghuangporus vaninii produces valuable bioactive compounds, but yields are low in artificial culture. While co-culture with microbes can elicit production, the regulatory potential of native endophytic fungi - which share an evolutionary history with their host - remains largely unexplored. In this study, we report for the first time a co-culture system between S. vaninii and its endophytic fungus Fusarium solani MF20 to enhance the production of medicinal metabolites and elucidate the underlying mechanisms.
resultsCo-culture with F. solani MF20 dramatically increased the yields of total flavonoids (9.38-fold), terpenoids (3.18-fold), and crude polysaccharides (4.87-fold) in S. vaninii. Integrated omics analyses revealed that the endophytic interaction induced global metabolic change in the host. Early signaling events, such as a controlled oxidative stress response, Ca2+ influx, extracellular ATP accumulation, and enhanced membrane permeability, were associated with the redirection of cellular resources from primary growth toward chemical defense. Key biosynthetic pathways, such as terpenoid backbone and flavonoid synthesis, were transcriptionally up-regulated, directly corroborated by the massive accumulation of bioactive compounds including the triterpene pachymic acid and complex modified flavonoids. Central carbon metabolism was reshaped, with activation of the pentose phosphate pathway potentially supplying NADPH for biosynthesis.
conclusionsThis work demonstrates that a native endophytic fungus can act as a powerful biotic elicitor to unlock the metabolic potential of its medicinal fungal host. The co-culture strategy activates a stress-mediated defense response that reprograms primary and secondary metabolism, leading to overproduction of pharmaceutically relevant compounds. Beyond providing insights into fungal-fungal symbiotic interactions, this study validates endophyte-host co-culture as an effective and sustainable bioprocess technology for enhancing the production of high-value metabolites from medicinal fungal resources.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.